S

Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336

Watchlist Manager
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
Watchlist
Price: 62.78 CNY -1.38% Market Closed
Market Cap: 38.7B CNY
Section:
 

Relative Value

The Relative Value of one Sunshine Guojian Pharmaceutical Shanghai Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 62.78 CNY, Sunshine Guojian Pharmaceutical Shanghai Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Sunshine Guojian Pharmaceutical Shanghai Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

31.3
P/S
P/S
Price to Sales
31.3
vs History
6
vs Industry
Median 3Y
14.6
Median 5Y
11.9
Industry
7.9
Forward
28
More Details
50.6
P/E
P/E
Price to Earnings
50.6
vs History
50
vs Industry
Median 3Y
91.9
Median 5Y
52.6
Industry
24
Forward
126.9
More Details
117.8
P/OCF
P/OCF
Price to OCF
117.8
vs History
19
vs Industry
Median 3Y
52
Median 5Y
47
Industry
21.6
More Details
1 668.3
P/FCFE
P/FCFE
Price to FCFE
1 668.3
vs History
7
vs Industry
Median 3Y
75.5
Median 5Y
-179.3
Industry
23.7
More Details
6.6
P/B
P/B
Price to Book Value
6.6
vs History
3
vs Industry
Median 3Y
2.8
Median 5Y
2.5
Industry
3.4
More Details
31.3
EV/S
EV/S
Enterprise Value to Sales
31.3
vs History
4
vs Industry
Median 3Y
14.2
Median 5Y
9.4
Industry
8.3
Forward
28
More Details
43.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
43.4
vs History
4
vs Industry
Median 3Y
18.9
Median 5Y
12.6
Industry
10.3
More Details
146.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
146.7
vs History
12
vs Industry
Median 3Y
100.6
Median 5Y
57
Industry
6.7
Forward
87.5
More Details
146.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
146.7
vs History
12
vs Industry
Median 3Y
100.6
Median 5Y
57
Industry
7.2
Forward
13.5
More Details
117.8
EV/OCF
EV/OCF
Enterprise Value to OCF
117.8
vs History
17
vs Industry
Median 3Y
47.9
Median 5Y
39.8
Industry
8.2
More Details
529
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
529
vs History
11
vs Industry
Median 3Y
210
Median 5Y
-76.6
Industry
6.7
More Details
4.4
EV/IC
EV/IC
Enterprise Value to IC
4.4
vs History
9
vs Industry
Median 3Y
3.1
Median 5Y
3
Industry
5.7
More Details

Multiples Across Competitors

Competitors Multiples
Sunshine Guojian Pharmaceutical Shanghai Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
38.7B CNY 31.3 50.6 146.7 146.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 071 784.8 -161 938.1 -196 644.6 -194 400.6
US
Abbvie Inc
NYSE:ABBV
398B USD 6.7 169.6 16.4 23.3
US
Amgen Inc
NASDAQ:AMGN
174.6B USD 4.9 24.9 18 18
US
Gilead Sciences Inc
NASDAQ:GILD
151B USD 5.2 18.6 12.5 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113B USD 9.6 30.8 22.5 23.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 067.7 -527.6 -574.5 -559.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
74.8B USD 5.2 16.3 15.5 17.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
57.1B USD 17.8 1 310.4 172.6 209.3
AU
CSL Ltd
ASX:CSL
89.8B AUD 3.8 19.9 13.3 16.6
NL
argenx SE
XBRU:ARGX
48B EUR 15.5 36.5 63.2 65
P/E Multiple
Earnings Growth PEG
CN
S
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
Average P/E: 186.4
50.6
-16%
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 938.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
169.6
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.9
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.6
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.8
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -527.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.3
9%
1.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 310.4
N/A N/A
AU
CSL Ltd
ASX:CSL
19.9
11%
1.8
NL
argenx SE
XBRU:ARGX
36.5
40%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
S
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
Average EV/EBITDA: 53.4
146.7
31%
4.7
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 644.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.4
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.5
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -574.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.5
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
172.6
N/A N/A
AU
CSL Ltd
ASX:CSL
13.3
8%
1.7
NL
argenx SE
XBRU:ARGX
63.2
807%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
S
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
Average EV/EBIT: 59.2
146.7
39%
3.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 400.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.3
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -559.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
13%
1.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
209.3
N/A N/A
AU
CSL Ltd
ASX:CSL
16.6
11%
1.5
NL
argenx SE
XBRU:ARGX
65
N/A N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 301,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.